Gabapentin Capsule
Product Images NDC 16571-869

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 16571-869). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 01)

Chemical structure of gabapentin showing the molecular arrangement including a cyclohexane ring bonded to an amino and a carboxyl group.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 02)

A line graph comparing mean pain scores over 8 weeks between placebo and gabapentin at 3600 mg/day. The x-axis represents weeks from baseline to week 8, with a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. The gabapentin group shows a decreasing trend in pain score, while the placebo group remains relatively stable.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 03)

Line graph showing mean pain scores over a 7-week period comparing placebo and two doses of gabapentin (1800 mg/day and 2400 mg/day). The x-axis represents weeks, including a 3-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10, with scores generally decreasing for gabapentin groups compared to placebo.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 04)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares the response rates of placebo (PBO) and gabapentin (GBP) at different doses across two studies. Study 1 shows 12% response for placebo and 29% for gabapentin 3600 mg. Study 2 shows 14% response for placebo, 32% for gabapentin 1800 mg, and 34% for gabapentin 2400 mg. Statistical significance is indicated for the gabapentin groups.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 05)

A scatter plot showing the difference percentage on the y-axis against daily dose in mg on the x-axis for gabapentin studies. Three studies, labeled a, b, and c, are represented by different shaded squares, plotting values at doses of 600, 900, 1200, and 1800 mg daily.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 06)

Gabapentin Capsules, USP 100 mg oral capsule label by Rising Pharma Holdings, Inc. The label includes the NDC 16571-867-03, states 30 capsules per container, and features storage instructions and dispensing warnings. It also lists manufacturing details for Rising Pharma Holdings, Inc. and Graviti Pharmaceuticals Pvt. Ltd.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 07)

Label for Gabapentin Capsules USP 300 mg by Rising Pharma Holdings, Inc. The label indicates the product contains 30 capsules, is for prescription use only, and includes storage instructions and dispensing information. Bar code and manufacturing details are also visible.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 08)

Gabapentin Capsules USP 400 mg label by Rising Pharmaceuticals, displaying the NDC 16571-869-03. The label indicates 30 capsules in the package, with instructions for pharmacists to dispense the accompanying Medication Guide. The label includes storage instructions, dosage guidance, and manufacturing details for Rising Pharma Holdings, Inc. and Graviti Pharmaceuticals Pvt. Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.